Clinical Oncology Next Generation Sequencing Ngs Market Size And Share

  • Report Code : TIPRE00007163
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

임상 종양학 차세대 시퀀싱(NGS) 시장 점유율 분석 및 기회 [2025-2031]

Buy Now

Clinical Oncology Next Generation Sequencing (NGS) Market Report Clinical Oncology Next Generation Sequencing (NGS) Market Scope and Analysis Clinical Oncology Next Generation Sequencing (NGS) Market Size and Share

Clinical Oncology Next Generation Sequencing (NGS) Market Report Analysis

Clinical Oncology Next Generation Sequencing (NGS) Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Agilent Technologies, Inc.
  • Caris Life Sciences
  • F. Hoffmann-La Roche Ltd
  • FOUNDATION MEDICINE, INC.
  • Illumina, Inc.
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc
  • QIAGEN

Regional Overview

  • 북미
  • 유럽
  • 아시아 태평양
  • 중남미
  • 중동 및 아프리카

Market Segmentation

By 기술
  • 전체 엑솜 시퀀싱
  • 전체 게놈 시퀀싱
  • 표적 시퀀싱 및 재배열
By 워크플로우
  • NGS 데이터 분석
  • NGS 사전 시퀀싱
  • NGS 시퀀싱
By 응용분야
  • 동반진단
  • 선별검사
  • 기타 응용분야
By 최종 사용자
  • 병원 및 진료소
  • 실험실